SPYRE THERAPEUTICS, INC. — Operating Income by Fiscal Year
12 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/609146c9-9320-4555-9ba7-d08110a71bcc/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-209.6M | 2025-01-01 – 2025-12-31 | evidence 0001636282-26-000020 |
| FY 2024 | $-208.6M | 2024-01-01 – 2024-12-31 | evidence 0001636282-25-000020 |
| FY 2023 | $-242.3M | 2023-01-01 – 2023-12-31 | evidence 0001636282-24-000005 |
| FY 2022 | $-84.8M | 2022-01-01 – 2022-12-31 | evidence 0000950170-23-005705 |
| FY 2021 | $-65.6M | 2021-01-01 – 2021-12-31 | evidence 0001564590-22-008995 |
| FY 2020 | $-81.5M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-014021 |
| FY 2019 | $-80.3M | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-005888 |
| FY 2018 | $-45.5M | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-006771 |
| FY 2017 | $-27.7M | 2017-01-01 – 2017-12-31 | evidence 0001564590-18-005404 |
| FY 2016 | $-21.9M | 2016-01-01 – 2016-12-31 | evidence 0001564590-17-005137 |
| FY 2015 | $-11.3M | 2015-01-01 – 2015-12-31 | evidence 0001564590-17-005137 |
| FY 2014 | $-8.9M | 2014-01-01 – 2014-12-31 | evidence 0001564590-17-005137 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).